|
E-DRUG Archives (by date)
November 29, 2002
-
[e-drug] Wed on para 6 negotiations: why things broke down
-
[e-drug] Act Up-Paris confronts EU Trade Commissioner
November 27, 2002
-
[e-drug] 7 Reasons to Reject A Bad Deal: CPTech Note to TRIPS Council Members
-
[e-drug] Letter from 6 Latin American and Indian generics associations on paragraph 6
-
[e-drug] Notes from Tuesday discussions on paragraph 6
-
[e-drug] Prices of subsidised drugs (cont)
-
[e-drug] Bad cop, more bad cops, Geneva negotiations on para 6
November 26, 2002
-
[e-drug] NGOs Say No to Poisonous Proposals on Paragraph 6
-
[e-drug] No exit strategy for para 6 negotiations?
-
[e-drug] Prices of subsidised drugs
November 23, 2002
-
[e-drug] Health organisation warns that kala-azar has returned to South Sudan
-
[e-drug] WTO wrestles with access to cheap drugs solution
-
[e-drug] Accountability of the pharmaceutical industry
-
[e-drug] Comments on Sydney WTO meeting
November 21, 2002
-
[e-drug] Consultation on pharmacogenetics and ethics
November 20, 2002
-
[e-drug] Lessons from Malarone donation program
-
[e-drug] Drug for chickens blamed for harder-to-treat food poisoning
-
[e-drug] 10.5 Million Children Vaccinated Against Hepatitis B
November 19, 2002
-
[e-drug] Nefazodone under investigation in the Netherlands
-
[e-drug] More on Roche vs MSF on nelfinavir
-
[e-drug] Distance training for junior scientists
November 16, 2002
-
[e-drug] Kenya PG programmes in Tropical Medicine and Infectious Diseases
-
[e-drug] The pharmaceutical industry as a medicines provider
-
[e-drug] Sigmed experience in Malawi
November 15, 2002
-
[e-drug] 25 years of essential medicines
-
[e-drug] WSJ on Roche's expensive ARVs
-
[e-drug] access vacancy in MSF-Holland
-
[e-drug] MSF on Sydney WTO meeting
November 14, 2002
-
[e-drug] Washington Post editorial on WTO mini in Sydney
-
[e-drug] WSJ on WTO Drugs - Sydney
-
[e-drug] IMF and the World Bank
-
[e-drug] WHO/EDM Technical Briefing
November 13, 2002
-
[e-drug] B & M Gates foundation and Microsoft
-
[e-drug] Open letter to Trade Ministers
-
[e-drug] WHO/EDM Technical Briefing documents
November 11, 2002
-
[e-drug] Messages not received by e-drug
-
[e-drug] Regulatory decisions in a globalised world
-
[e-drug] RFI patent legislation
November 10, 2002
-
[e-drug] Dipyrone(metamizole) (cont)
-
[e-drug] Dipyrone (metamizole)(cont)
-
[e-drug] Review of Pharmacist Services
November 09, 2002
-
[e-drug] EU clamps down on reimportation
-
[e-drug] Dipyrone (metamizole) and risk of agranulocytosis
November 07, 2002
-
[e-drug] EU parliament on production for export:
-
[e-drug] Analysis of South Africa's NDP process
-
[e-drug] Mefloquin for malaria prophylaxis (cont)
-
[e-drug] Mefloquin for malaria prophylaxis (cont)
November 06, 2002
-
[e-drug] ICIUM 2004 Preliminary Announcement
-
[e-drug] Pharmacy regulation (cont)
-
[e-drug] Mefloquin for malaria prophylaxis (cont)
-
[e-drug] Essential drugs missing from market (cont)
November 05, 2002
-
[e-drug] Pharmacy Regulation (cont)
-
[e-drug] Mefloquin for malaria prophylaxis (cont)
November 04, 2002
-
[e-drug] open MSF letter to Roche on nelfinavir
November 03, 2002
-
[e-drug] Short course in pharmacoeconomics and drug selection
-
[e-drug] Wholesale and retail markups on essential drugs in developing countries (cont)
-
[e-drug] Mefloquin for malaria prophylaxis (cont)
-
[e-drug] Mefloquin for malaria prophylaxis (cont)
-
[e-drug] Medicines, society, and industry
-
[e-drug] Essential drugs missing from market (cont)
-
[e-drug] Mefloquin for malaria prophylaxis
November 01, 2002
-
[e-drug] Wholesale and retail markups on essential drugs in developing countries
-
[e-drug] Therapeutics Letter 45: Do Single Stereoisomer Drugs Provide Value?
October 31, 2002
-
[e-drug] Cessation of trading activities at ECHO International Health
-
[e-drug] Pharmacy Regulation (cont)
Mail converted by MHonArc 2.6.8
|
| |